Loading…
Comparative pharmacokinetics of two extended half‐life FVIII concentrates (Eloctate and Adynovate) in adolescents with hemophilia A: Is there a difference?
Carcao, Manuel D., Chelle, Pierre, Clarke, Emily, Kim, Lussia, Tiseo, Laura, Morfini, Massimo, Hossain, Taneya, Rand, Margaret L., Brown, Christine, Edginton, Andrea N., Lillicrap, David, Iorio, Alfonso, Blanchette, Victor S.
Published in Journal of thrombosis and haemostasis (01.07.2019)
Published in Journal of thrombosis and haemostasis (01.07.2019)
Get full text
Journal Article
Loading…
Recombinant full-length factor VIII (FVIII) and extended half-life FVIII products in prophylaxis - new insight provided by pharmacokinetic modelling
Gringeri, A., Wolfsegger, M., Steinitz, K. N., Reininger, A. J.
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.05.2015)
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.05.2015)
Get full text
Journal Article
Loading…
Extended half‐life pegylated, full‐length recombinant factor VIII for prophylaxis in children with severe haemophilia A
Mullins, E. S., Stasyshyn, O., Alvarez‐Román, M. T., Osman, D., Liesner, R., Engl, W., Sharkhawy, M., Abbuehl, B. E.
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.03.2017)
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.03.2017)
Get full text
Journal Article
Loading…
Perspective – The case for zero bleeds and drug bioequivalence in the treatment of congenital hemophilia A in 2021
Di Minno, Alessandro, Spadarella, Gaia, Esposito, Salvatore, Mathew, Prasad, Di Minno, Giovanni, Mannucci, Pier Mannuccio
Published in Blood reviews (01.11.2021)
Published in Blood reviews (01.11.2021)
Get full text
Journal Article